京都大学大学院医学研究科眼科学 講師

日本糖尿病眼学会 常務理事 日本眼科学会 会員 日本網膜硝子体学会 会員 日本眼科医会 会員 日本眼循環学会 会員 日本眼光学学会 会員 The Association for Research in Vision and Ophthalmology（ARVO） 会員 American Academy of Ophthalmology（AAO） 会員

村上 智昭 むらかみ ともあき 先生

公開日
2023/10/30

基本情報

診療科・主な得意領域

  • 眼科
  • 糖尿病網膜症
    詳細
    村上先生の糖尿病網膜症の専門領域
    • 硝子体手術
    • 網膜光凝固
  • 糖尿病黄斑浮腫
    詳細
    村上先生の糖尿病黄斑浮腫の専門領域
    • 抗VEGF療法

続きを読む

資格・学会・役職

日本糖尿病眼学会 常務理事
日本眼科学会 会員
日本網膜硝子体学会 会員
日本眼科医会 会員
日本眼循環学会 会員
日本眼光学学会 会員
The Association for Research in Vision and Ophthalmology（ARVO） 会員
American Academy of Ophthalmology（AAO） 会員
  • 京都大学大学院医学研究科眼科学 講師

医療記事

来歴等

略歴

1999年 京都大学医学部附属病院 眼科研修医
2000年 公立豊岡病院 眼科医員
2002年 京都大学大学院医学研究科 博士課程
2006年 京都大学医学部附属病院 眼科医員
2006年 Penn State College of Medicine 博士研究員
2009年 京都大学医学部附属病院 助教
2019年 同上 講師

論文

  • 1. Pathological Neurovascular Unit Mapping onto Multimodal Imaging in Diabetic Macular Edema. Medicina (Kaunas). 2023 May 7;59(5):896. doi: 10.3390/medicina59050896.

    Murakami T, Ishihara K, Terada N, Nishikawa K, Kawai K, Tsujikawa A.

  • 2. Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy. Ophthalmol Sci. 2022 Nov 2;3(1):100241. doi: 10.1016/j.xops.2022.100241.

    Kawai K, Murakami T, Mori Y, Ishihara K, Dodo Y, Terada N, Nishikawa K, Morino K, Tsujikawa A.

  • 3. Clinical Relevance of Parafoveal Intercapillary Spaces and Foveal Avascular Zone in Diabetic Retinopathy Without Macular Edema. Invest Ophthalmol Vis Sci. 2022 Nov 1;63(12):4. doi: 10.1167/iovs.63.12.4.

    Terada N, Murakami T, Ishihara K, Dodo Y, Nishikawa K, Kawai K, Tsujikawa A.

  • 4. Factors predicting the treatment frequency of ranibizumab injections during the second year in diabetic macular edema. Jpn J Ophthalmol. 2022 May;66(3):296-304. doi: 10.1007/s10384-022-00905-4.

    Nishikawa K, Murakami T, Ishihara K, Dodo Y, Terada N, Morino K, Tsujikawa A.

  • 5. Hyperreflective Walls in Foveal Cystoid Spaces as a Biomarker of Diabetic Macular Edema Refractory to Anti-VEGF Treatment. Sci Rep. 2020 Apr 29;10(1):7299. doi: 10.1038/s41598-020-64332-6.

    Terada N, Murakami T, Uji A, Dodo Y, Mori Y, Tsujikawa A.

  • 6. Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema. Sci Rep. 2020 Jan 21;10(1):873. doi: 10.1038/s41598-020-57646-y.

    Yoshitake T, Murakami T, Suzuma K, Dodo Y, Fujimoto M, Tsujikawa A.

  • 7. Disproportion of lamellar capillary non-perfusion in proliferative diabetic retinopathy on optical coherence tomography angiography. Br J Ophthalmol. 2020 Jun;104(6):857-862. doi: 10.1136/bjophthalmol-2019-314743.

    Uchitomi D, Murakami T, Dodo Y, Yasukura S, Morino K, Uji A, Yoshitake T, Fujimoto M, Tsujikawa A.

  • 8. Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab. Sci Rep. 2019 May 20;9(1):7599. doi: 10.1038/s41598-019-44078-6.

    Yoshitake T, Murakami T, Suzuma K, Fujimoto M, Dodo Y, Tsujikawa A.

  • 9. Anti-Fumarase Antibody as a Predictor of Functional Efficacy of Anti-VEGF Therapy for Diabetic Macular Edema. Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):787-794. doi: 10.1167/iovs.18-26209.

    Yoshitake T, Murakami T, Yoshitake S, Suzuma K, Dodo Y, Fujimoto M, Tsujikawa A.

  • 10. Anti-fumarase antibody promotes the dropout of photoreceptor inner and outer segments in diabetic macular oedema. Diabetologia. 2019;62(3):504-16. doi: 10.1007/s00125-018-4773

    Yoshitake S, Murakami T, Suzuma K, Yoshitake T, Uji A, Morooka S, Dodo Y, Fujimoto M, Shan Y, Fort PE, Ito S, Tsujikawa A, Yoshimura N.

  • 11. Diabetic Nonperfused Areas in Macular and Extramacular Regions on Wide-Field Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2018;59(15):5893-903. doi: 10.1167/iovs.18-25108.

    Yasukura S, Murakami T, Suzuma K, Yoshitake T, Nakanishi H, Fujimoto M, Oishi M, Tsujikawa A.

  • 12. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema. Jpn J Ophthalmol. 2018;62(3):292-301. doi: 10.1007/s10384-018-0575-8.

    Murakami T, Suzuma K, Uji A, Yoshitake S, Dodo Y, Fujimoto M, Yoshitake T, Miwa Y, Yoshimura N.

  • 13. Diabetic Neuroglial Changes in the Superficial and Deep Nonperfused Areas on Optical Coherence Tomography Angiography. Invest Ophthalmol Vis Sci. 2017;58(13):5870-9. doi: 10.1167/iovs.17-22156.

    Dodo Y, Murakami T, Suzuma K, Yoshitake S, Yoshitake T, Ishihara K, Fujimoto M, Miwa Y, Tsujikawa A.

  • 14. Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema. PLoS One. 2017;12(4):e0175809. doi: 10.1371/journal.pone.0175809.

    Mori Y, Murakami T, Suzuma K, Ishihara K, Yoshitake S, Fujimoto M, Dodo Y, Yoshitake T, Miwa Y, Tsujikawa A.

  • 15. Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema. Sci Rep. 2016;6:39161. doi: 10.1038/srep39161.

    Mori Y, Suzuma K, Uji A, Ishihara K, Yoshitake S, Fujimoto M, Dodo Y, Yoshitake T, Miwa Y, Murakami T.

  • 16. Characterization of Inner Retinal Spots With Inverted Reflectivity on En Face Optical Coherence Tomography in Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2016;57(4):1862-70. doi: 10.1167/iovs.16-19171.

    Yoza R, Murakami T, Uji A, Suzuma K, Yoshitake S, Dodo Y, Ghashut R, Fujimoto M, Miwa Y, Yoshimura N.

  • 17. Kallikrein-Kinin System: An Emerging Competitor or Collaborator for VEGF in Diabetic Macular Edema? Diabetes. 2015;64(10):3350-2. doi: 10.2337/db15-0746

    Murakami T.

  • 18. Macular morphologic findings on optical coherence tomography after microincision vitrectomy for proliferative diabetic retinopathy. Jpn J Ophthalmol. 2015;59(4):236-43. doi: 10.1007/s10384-015-0382-4.

    Murakami T, Uji A, Ogino K, Unoki N, Yoshitake S, Dodo Y, Horii T, Nishijima K, Yoshimura N.

  • 19. Disorganized retinal lamellar structures in nonperfused areas of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015;56(3):2012-20. doi: 10.1167/iovs.14-15924.

    Dodo Y, Murakami T, Uji A, Yoshitake S, Yoshimura N.

  • 20. Qualitative and quantitative characteristics of near-infrared autofluorescence in diabetic macular edema. Ophthalmology. 2014;121(5):1036-44. doi: 10.1016/j.ophtha.2013.11.033.

    Yoshitake S, Murakami T, Horii T, Uji A, Ogino K, Unoki N, Nishijima K, Yoshimura N.

  • 21. Integrative understanding of macular morphologic patterns in diabetic retinopathy based on self-organizing map. Invest Ophthalmol Vis Sci. 2014;55(3):1994-2003, 2014. doi: 10.1167/iovs.13-13417.

    Murakami T, Ueda-Arakawa N, Nishijima K, Uji A, Horii T, Ogino K, Yoshimura N.

  • 22. Association between Perifoveal Hyperfluorescence and Serous Retinal Detachment in Diabetic Macular Edema. Ophthalmology. 2013;120(12):2596-603. doi: 10.1016/j.ophtha.2013.06.014.

    Murakami T, Uji A, Ogino K, Unoki N, Horii T, Yoshitake S, Nishijima K, Yoshimura N.

  • 23. Macular Migration toward the Optic Disc after Inner Limiting Membrane Peeling for Diabetic Macular Edema.Invest Ophthalmol Vis Sci. 2013;54(1):629-35. doi: 10.1167/iovs.12-10907.

    Yoshikawa M, Murakami T, Nishijima K, Uji A, Ogino K, Horii T, Yoshimura N.

  • 24. Segmentational analysis of retinal thickness after vitrectomy in diabetic macular edema. Invest Ophthalmol Vis Sci. 2012;53(10):6668-74. doi: 10.1167/iovs.12-9934.

    Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda-Arakawa N, Muraoka Y, Yoshimura N.

  • 25. Protein kinase cβ phosphorylates occludin regulating tight junction trafficking in vascular endothelial growth factor-induced permeability in vivo. Diabetes. 2012;61(6):1573-83. doi: 10.2337/db11-1367.

    Murakami T, Frey T, Lin C, Antonetti DA.

  • 26. Relationship between Fluorescein Pooling and Optical Coherence Tomographic Reflectivity of Cystoid Spaces in Diabetic Macular Edema. Ophthalmology. 2012;119(5):1047-55. doi: 10.1016/j.ophtha.2011.10.030.

    Horii T, Murakami T, Nishijima K, Akagi T, Uji A, Arakawa N, Muraoka Y, Yoshimura N.

  • 27. Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. Invest Ophthalmol Vis Sci. 2012;53(3):1506-11. doi: 10.1167/iovs.11-9231.

    Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda-Arakawa N, Muraoka Y, Yoshimura N.

  • 28. Foveal Cystoid Spaces Are Associated with Enlarged Foveal Avascular Zone and Microaneurysms in Diabetic Macular Edema. Ophthalmology. 2011;118(2):359-67. doi: 10.1016/j.ophtha.2010.03.035.

    Murakami T, Nishijima K, Sakamoto A, Ota M, Horii T, Yoshimura N.

  • 29. Association of Pathomorphology, Photoreceptor Status, and Retinal Thickness with Visual Acuity in Diabetic Retinopathy. Am J Ophthalmol. 2011;151(2):310-7. doi: 10.1016/j.ajo.2010.08.022.

    Murakami T, Nishijima K, Sakamoto A, Ota M, Horii T, Yoshimura N.

  • 30. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284(31):21036-46. doi: 10.1074/jbc.M109.016766.

    Murakami T, Felinski EA, Antonetti DA.

特許

  • 1. 村上智昭, 吉村長久. 網膜新生血管に対する薬物効果の新規評価システム. 特許第4961547号、2012. 日本

受賞

  • 1. 2016年 第10回 日本糖尿病眼学会 福田賞

本ページにおける情報は、医師本人の申告に基づいて掲載しております。内容については弊社においても可能な限り配慮しておりますが、最新の情報については公開情報等をご確認いただき、またご自身でお問い合わせいただきますようお願いします。

なお、弊社はいかなる場合にも、掲載された情報の誤り、不正確等にもとづく損害に対して責任を負わないものとします。